TLR4 and viral infectious disease: Since TLR4 antagonists reduced influenza-induced mortality in rats, neutrophils could enhance susceptibility by deriving oxidized phospholipids (TLR4 agonists) and neutrophil proteases can also degrade antiviral peptides, which eliminated viral load and directly averted susceptibility to viral infection [41, 42].